# A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes

> **NCT07668999** · PHASE1 · RECRUITING · sponsor: **Sinomune Pharmaceutical Co., Ltd** · enrollment: 64 (estimated)

## Conditions studied

- Tinea Pedis

## Interventions

- **DRUG:** ZYG24004 1% topical film-forming formulation
- **DRUG:** ZYG24004 3% topical film-forming formulation
- **DRUG:** Placebo topical formulation

## Key facts

- **NCT ID:** NCT07668999
- **Lead sponsor:** Sinomune Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-21
- **Primary completion:** 2027-06-10
- **Final completion:** 2027-06-10
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668999, "A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*